Coffee intake and chronic hepatitis C

Hepatology

Volumn 50, Issue 5, 2009, Pages 1673-

  Purnak, Tugrul ^a   Ozaslan, Ersan ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CYTOCHROME P450 1A2;

ALCOHOL CONSUMPTION; COFFEE; DISEASE COURSE; ENZYME ACTIVITY; ENZYME INHIBITION; FLUID INTAKE; FOOD COMPOSITION; FOOD SAFETY; HEPATITIS C; HUMAN; LETTER; LIVER DISEASE; PATIENT SAFETY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOKING;

ANTIVIRAL AGENTS; CAFFEINE; COFFEE; CYTOCHROME P-450 CYP1A2; DISEASE PROGRESSION; DRINKING BEHAVIOR; DRUG INTERACTIONS; HEPATITIS C, CHRONIC; HUMANS; PHOSPHODIESTERASE INHIBITORS;

EID: 72949085761     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23243     Document Type: Letter

References (4)

1. Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, et al. The HALT-C Trial Group. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. HEPATOLOGY 2009; doi:10.1002/hep.23162.
2. Cadden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment Pharmacol Ther 2007;26:1-8.
3. Chou T. Wake up and smell the coffee. Caffeine, coffee, and the medical consequences. West J Med 1992;157:544-553.
4. Carrillo JA, Benitez J. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 2000;39:127-153.